Startseite ProdukteMedizinische Testmaterialien

Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method

Bescheinigung
China Sichuan Hundred Medcal Technology Co., Ltd. zertifizierungen
China Sichuan Hundred Medcal Technology Co., Ltd. zertifizierungen
Ich bin online Chat Jetzt

Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method

Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method
Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method

Großes Bild :  Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method

Produktdetails:
Herkunftsort: CHINA
Markenname: DVOT
Zertifizierung: /
Modellnummer: /
Zahlung und Versand AGB:
Min Bestellmenge: 1000 Prozent
Preis: Verhandelbar
Verpackung Informationen: KARTON
Lieferzeit: 10-15 Tage
Zahlungsbedingungen: L/C, T/T, Westenunion, Geld Gramm, Paypal/VTB
Versorgungsmaterial-Fähigkeit: 100000 PC/Monat
Kontakt Plaudern Sie Jetzt

Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method

Beschreibung
Produktname: Antigen-Kombi-Testkit für Atemwegsinfektionen Genauigkeit: 98%
Verfahren: Kolloidales Gold Testzeit: 8 Min
Probentyp: Nasenabstrich Spezifikation: Kits für 1T, 5T, 25T
Hervorheben:

98% Accuracy Respiratory Infection Antigen Combo Test Kit

,

8 Mins Test Time Rapid Lateral Flow Immunoassay

,

Colloidal Gold Method Self-Testing Kit

Respiratory Infection Antigen Combo Test Kit 8 Minutes Easy Self-Testing Kit
Product Overview
The Respiratory Infection Antigen Combo Test Kit is a rapid lateral flow immunoassay designed for simultaneous qualitative detection of SARS-CoV-2, Influenza A, and Influenza B viral antigens from shallow nasal swab samples. This all-in-one diagnostic solution enables differential diagnosis of three major respiratory pathogens in a single test, providing results within minutes for early intervention.
Key Features & Advantages
  • Triple Target Detection: Identifies SARS-CoV-2 (including variants: Alpha, Delta, Omicron BA.4/BA.5, CH.1.1, EG.5, JN.1, XDV.1) and Influenza A/B strains (H1N1, H3N2, H1N1pdm09, Yamagata, Victoria) with one swab.
  • High Accuracy & Efficiency: Demonstrates >98% sensitivity for early infection detection (SARS-CoV-2 within 7 days, Influenza A/B within 4 days of symptom onset), reducing false negatives.
  • Rapid Results: Clear visual results within 8 minutes, allowing quick distinction between viruses with overlapping symptoms (e.g., fever, cough) for appropriate treatment.
  • User-Centered Design: Painless shallow nasal swabbing suitable for adults and children; no instruments or specialized training required.
  • Cost-Effective Surveillance: Eliminates need for multiple tests or lab delays, ideal for households, schools, or workplaces during peak infection seasons.
Application Scenarios
  • Seasonal Outbreaks: Critical for flu seasons (Jan-Apr, Jul-Aug) and COVID-19 surges to differentiate pathogens.
  • High-Risk Settings: Protects vulnerable groups (immunocompromised individuals, elderly, children) in schools, hospitals, nursing homes.
  • Home Self-Testing: Enables families to screen symptomatic members promptly, minimizing community transmission.
  • Travel or Public Events: Provides pre-screening assurance for gatherings or international travel compliance.
Clinical Value
By distinguishing SARS-CoV-2 from influenza infections early, the kit helps avoid inappropriate antibiotic use, supports targeted antiviral treatment (e.g., Tamiflu for influenza), and guides isolation protocols. Its reliability with circulating variants ensures relevance in evolving pandemic landscapes. Results should be correlated with clinical symptoms and epidemiological data; positive outcomes warrant confirmation through molecular tests when needed.
Operational Procedure
  1. Collect sample via painless shallow nasal swab.
  2. Insert swab into extraction buffer tube.
  3. Apply solution to test cartridge.
  4. Read results at 8 minutes—distinct lines indicate specific viruses.
Specifications
Shelf Life 24 months
Keyword Respiratory Infection Antigen Combo Test Kit
Usage Professional Testing
Application Home Hospital
Product Images
Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method 0
Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method 1
Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method 2
Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method 3

Kontaktdaten
Sichuan Hundred Medcal Technology Co., Ltd.

Ansprechpartner: Mr. Terry

Telefon: 15008220675

Senden Sie Ihre Anfrage direkt an uns (0 / 3000)